So what are they actually doing about it? Today on the show, we’ll do the numbers. The 100 most-common brand-name pharmaceuticals got 232 percent more expensive in the past decade. State lawmakers have filed more than 150 bills this year to rein in costs, something 80 percent of people surveyed by Kaiser agree we need. Some drug companies are starting to feel the squeeze from their own shareholders, too. We’ll talk about it. But first: U.S. Immigration and Customs Enforcement has more than doubled workplace investigations over last year. Audits and arrests are up, too. We’ll look at the economics of these raids. Plus: Uber and Lyft are changing the way they handle sexual harassment and assault claims. (05/15/2018)